PlainRecalls
FDA Drug Moderate Class II Terminated

Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059, NDC 69097-527-34

Reported: January 6, 2021 Initiated: December 17, 2020 #D-0181-2021

Product Description

Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059, NDC 69097-527-34

Reason for Recall

Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline

Details

Recalling Firm
CIPLA
Units Affected
284,610 packets
Distribution
U.S.A. Nationwide
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059, NDC 69097-527-34. Recalled by CIPLA. Units affected: 284,610 packets.
Why was this product recalled?
Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline
Which agency issued this recall?
This recall was issued by the FDA Drug on January 6, 2021. Severity: Moderate. Recall number: D-0181-2021.